Skip to content
Tenfell
Awarded contract
Published 04 Sep 2025

NHS National Framework for Transition products (Axitinib and Eltrombopag)

NHS England · London

Key facts

Awarded
17 Aug 2025
Contract starts
30 Sep 2025
Contract ends
31 Jan 2027
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 7 suppliers

SupplierValue
Dr Reddy's Laboratories (UK) Ltd—
Pfizer Ltd—
Teva UK Ltd—
Thornton & Ross Ltd—
Wockhardt UK Limited—
Novartis Pharmaceuticals UK Ltd—
Perennial Pharma Ltd—

Description

Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025 Offer reference number: CM/TNS/25/5722 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5722/01 Axitinib and Eltrombopag Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months) Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months) Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.